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Abstract
Background: Patients suffering from cutaneous leishmaniasis (CL) caused by New World Leishmania (Viannia) species are at
high risk of developing mucosal (ML) or disseminated cutaneous leishmaniasis (DCL). After the formation of a primary skin
lesion at the site of the bite by a Leishmania-infected sand fly, the infection can disseminate to form secondary lesions. This
metastatic phenotype causes significant morbidity and is often associated with a hyper-inflammatory immune response
leading to the destruction of nasopharyngeal tissues in ML, and appearance of nodules or numerous ulcerated skin lesions
in DCL. Recently, we connected this aggressive phenotype to the presence of Leishmania RNA virus (LRV) in strains of L.
guyanensis, showing that LRV is responsible for elevated parasitaemia, destructive hyper-inflammation and an overall
exacerbation of the disease. Further studies of this relationship and the distribution of LRVs in other Leishmania strains and
species would benefit from improved methods of viral detection and quantitation, especially ones not dependent on prior
knowledge of the viral sequence as LRVs show significant evolutionary divergence.
Methodology/Principal Findings: This study reports various techniques, among which, the use of an anti-dsRNA
monoclonal antibody (J2) stands out for its specific and quantitative recognition of dsRNA in a sequence-independent
fashion. Applications of J2 include immunofluorescence, ELISA and dot blot: techniques complementing an arsenal of other
detection tools, such as nucleic acid purification and quantitative real-time-PCR. We evaluate each method as well as
demonstrate a successful LRV detection by the J2 antibody in several parasite strains, a freshly isolated patient sample and
lesion biopsies of infected mice.
Conclusions/Significance: We propose that refinements of these methods could be transferred to the field for use as a
diagnostic tool in detecting the presence of LRV, and potentially assessing the LRV-related risk of complications in
cutaneous leishmaniasis.
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Introduction
Leishmaniasis is one of the most important human protozoan
parasitic diseases worldwide, with a prevalence of 12 million
infections and a further 350 million people living at risk across 98
countries [1,2]. It mainly presents in two major clinical forms: 1)
cutaneous leishmaniasis (CL) in which lesions are generally
localized and self-healing or 2) visceral leishmaniasis (VL) known
to fatally disseminate to viscera. CL can be caused by various
species, either from the Leishmania (Leishmania) subgenus (e.g. L.
major, L. mexicana and L. amazonensis) or members of the L. (Viannia)
subgenus (e.g. L. braziliensis, L. panamensis and L. guyanensis), while VL
is mostly attributed to L. donovani, L. infantum and L. chagasi. Beyond
the intrinsic parasite factors that seem to determine disease
phenotype, extrinsic factors within the host are also known to alter
the symptomatic spectrum of leishmaniasis [3].
In South America, CL patients mainly infected by L. braziliensis,
L. panamensis and L. guyanensis are at risk for developing mucosal
(ML) or disseminated cutaneous leishmaniasis (DCL) [3,4,5,6],
which are complications of CL involving dissemination of parasites
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from primary lesions to secondary sites, with or without mucosal
involvement, and causing lesions that are often associated with a
highly destructive inflammatory response [7,8,9,10]. Mucosal
disease is notorious for its poor response to commonly used
treatments, such as antimony, and is often complicated by
secondary bacterial or fungal infections. Very little is known
about the pathogenesis of metastatic and mucosal leishmaniasis;
especially the source of the uncontrolled inflammatory response
observed in some patients. Two factors that have been associated
with mucosal and disseminated disease include host genetic
polymorphisms (e.g. in TNF, IL-6 and HLA genes) and HIV co-
infection [11,12,13].
Recently, we suggested that the presence of a parasite dsRNA
virus could contribute to the severity of the disease in strains of L.
guyanensis [14,15,16]. This Leishmania dsRNA virus (LRV) has been
found in various L. (Viannia) species as well as in one L. major strain
[17]. Notably, in murine models of L. guyanensis infection, the LRV
dsRNA genome is innately recognized by host Toll-like-receptor
(TLR3), exacerbating the disease in a dose-dependent manner
[14,15].
Leishmania has a digenetic life cycle, with a motile extracellular
promastigote form in the midgut of a female sand fly, and a non-
motile intracellular amastigote form in the mammalian host
macrophage. Our model proposes that the innate recognition of
LRV takes place in the first few hours of infection. Here, some
fraction of parasites die, releasing viral dsRNA that then binds to
Toll-like receptor 3 (TLR3) trigging the subsequent IFN-type I
driven inflammatory cascade that worsens disease [14,18]. A high
LRV burden in infecting parasites could therefore be a major
determinant of disease severity and pathology.
LRV is a member of the Totiviridae family that regroups viruses
found in several kingdoms of life [16], including protozoan
parasites such as Giardia, Trichomonas vaginalis, fungi such as
Helminthosporium sp. and S. cerevisiae as well as mosquitoes [19] and
salmon [20]. They are small and simple virions (30–50 nm),
containing a dsRNA genome that encodes its single capsid protein
and an RNA-dependant RNA polymerase (RdRp), necessary and
sufficient for both viral genomic dsRNA replication and viral
ssRNA transcription. Viral transcripts are translated in the host
cell cytoplasm into a capsid protein and, in most Totiviridae, into a
fusion capsid-RdRp polypeptide (82 kDa and 176 kDa respec-
tively). According to detailed studies in yeast, a single virion is
composed of more than a hundred capsid protein molecules and
one to two capsid-RdRp subunits surrounding the single genomic
dsRNA molecule [21]. LRVs were identified and characterized
several years ago in L. (Viannia) braziliensis and guyanensis [22,23,24]
as well as in a single isolate of L. major [17]. Although their
genomic organization is identical, high diversity in nucleotide
sequence (less than 40% homology according to [17]) between
LRVs of L. (Viannia) and L. major has categorized Leishmania viruses
into the groups LRV1 and LRV2 respectively [17].
An important finding from our prior work is that only parasites
with high levels of LRV exacerbated disease severity [14,15], and
previous studies have shown that considerable diversity in
sequence is found amongst LRVs [17]. Studies looking into the
role of LRV would thus be greatly aided by the availability of
diverse methods for LRV detection and quantification, especially
simple, rapid and reliable techniques, suitable for screening a large
number of parasite strains in the field. To this end, we used
parasite strains bearing different levels of LRV as standards [14].
Reliable detection and quantification was achieved by dsRNA
extraction, quantitative real-time PCR (qRT-PCR) as well as with
the immuno-detection of LRV genome in lysed, fixed or live
parasite samples (ELISA, dot blot and fluorescence microscopy).
Although qRT-PCR can be used efficiently and is a powerful
method for detailed molecular studies on reference strains, it could
have limited application for LRV screening on uncharacterized
parasites from the field due to possible nucleotide and amino acid
polymorphisms of LRVs. This problem was addressed by focusing
on detection of dsRNA through the use of an anti-dsRNA
monoclonal antibody (J2), which specifically recognizes dsRNA
independent of its underlying nucleotide sequence. We applied this
approach on several catalogued human isolates, on a fresh L.
braziliensis sample obtained from a patient as well as on murine
lesions biopsies, showing the relative ease of use of these methods
for field application. We propose the technique as having great
diagnostic potential for predicting the LRV-related risk of
leishmanial dissemination.
Methods
Ethical statement
This study was approved by the Ethics Committee of Canton of
Vaud, Lausanne (Switzerland) for the analysis of Leishmania
parasites isolated from patients. The two L. braziliensis parasites
strains (MHOM/BO/2011/2169 and MHOM/BO/2011/2192)
were isolated from a L. braziliensis infected patient, who signed an
informed consent accepting the use of materials for publication.
Other Leishmania parasite strains used in this study are common
lines isolated several years ago and described in several reports.
Parasite strains and cultures
Different L. guyanensis reference strains of known LRV content
[14] were used: i) two clones derived from the M4147 population
(MHOM/BR/75/M4147) infected or not by LRV designated
here as Lg M4147 LRVhigh (M4147/SSU:IRSAT-LUC(b)) and Lg
M4147 LRVneg (M4147/pX63HXG/SSU:IRSAT-LUC(b)) respec-
tively [25], ii) human isolates of L. guyanensis Lg 1398 (MHOM/
BR/89/IM3597) and Lg 1881 (MHOM/BR/92/IM3862) and iii)
L. guyanensis M5313 parasites (WHI/BR/78/M5313) and their
derived non-metastatic (Lg 03 and Lg 17) or metastatic (Lg 13 and
Lg 21) clones [14,26]. Five human isolates of L. braziliensis,
previously shown to be LRV-infected [24], were also analyzed:
Author Summary
The endosymbiosis of viruses in microbes is a well-
described and prevalent environmental partnership, where
viruses offer their cellular host incentives of fitness in
exchange for the use of their metabolic machinery. We
have recently exposed this as an important factor in
certain metastatic leishmaniases of South America, where
the nucleic acid of a virus residing within some Leishmania
parasites acts as a potent innate immunogen causing a
destructive inflammatory response, which worsens dis-
ease. Leishmania RNA Virus (LRV) exists within many
species of Leishmania as a stable infection; these LRV
positive strains have been found throughout South
America in cutaneous leishmaniases that are often
complicated by the occurrence of infectious metastasis
with an underlying hyperinflammatory response. In this
report, we describe the use of an anti-dsRNA monoclonal
antibody (J2), which specifically recognizes dsRNA in a
quantitative and sequence-independent fashion. Refined
versions of these methods could be transferred to the field
as diagnostic tools for detecting the presence of LRV (or
other dsRNA viruses), and potentially assessing the LRV-
related risk of complicated cutaneous leishmaniasis.
Leishmania RNA Virus Detection
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MHOM/CO/88/1407C (Lb 1407C), MHOM/CO/88/1407M
(Lb 1407M), MHOM/CO/88/1403 (Lb 1403), MHOM/CO/86/
1174 (Lb 1174) and MHOM/CO/84/1064 (Lb 1064). Two strains
of L. braziliensis parasites were freshly isolated from an infected
patient who contracted leishmaniasis: MHOM/BO/2011/2169
(from primary cutaneous lesion) and MHOM/BO/2011/2192
(from secondary/metastatic lesion), referred to in the text as Lb
2169 and Lb 2192.
Parasites were cultivated as promastigotes at 26uC in freshly
prepared Schneider’s insect medium (Sigma) supplemented with
10% heat-inactivated fetal bovine serum (PAA), 10 mM Hepes
(Amimed), 50 U/ml penicillin/streptomycin (Amimed), 0.6 mg/L
biopterin (Sigma) and 5 mg/L hemin (Sigma).
Viral dsRNA extraction from total nucleic acids
Stationary phase Leishmania promastigotes were lysed for 20 min
at RT with 0.4% sarkosyl and protease inhibitors (Roche) diluted
in 16PBS (108 parasites in 100 ml). The lysates were then
incubated at 37uC, first for 30 min with 400 mg/ml of recombi-
nant proteinase K (Roche), then for a further 2 h with 10 mg/ml
RNase (DNase-free from Roche). Nucleic acids, containing
genomic parasitic DNA and LRV dsRNA, were extracted from
these lysates by phenol-chloroform (at least twice), precipitated
with 0.3 M sodium-acetate in 70% ethanol, then washed and
resuspended in water (approx. 20 ml for 108 parasites). DNA was
quantified by spectrophotometry (Nanodrop). Pure viral dsRNA
was obtained after RQ-DNase digestion according to manufac-
turer’s instruction (Promega). Nucleic acids were analysed on 0.6%
to 1.2% agarose gels containing SYBR-safe for nucleic acid
staining (Invitrogen).
Quantitative real-time PCR (qRT-PCR)
RNA was extracted from stationary phase promastigotes
(approx. 36107) using Trizol (Invitrogen) according to manufac-
turer’s instruction (1 ml Trizol for a 1 ml promastigote culture).
After extraction, precipitation and washing, RNA was resus-
pended in water (36107 parasites in 10 ml) and quantified by
spectrophotometry. 0.5–1 mg of RNA was then used for cDNA
synthesis with SuperScript II Reverse Transcriptase (Invitrogen),
which was finally purified with a QIAquick PCR purification kit
(Qiagen). qRT-PCR was undertaken in a reaction solution of
0.5 mM primer diluted in SYBR Green Master mix (LightCycler
480 system, Roche). The reaction consisted of an initial
denaturation at 95uC for 5 min followed by 40 cycles of
amplification: 10 s at 95uC, 10 s at 60uC, 10 s at 72uC and a
fluorescence detection step at 78uC to quantify the amplified DNA
after each cycle. The following DNA oligonucleotides (Microsynth,
Switzerland) were used: SetA: 59-CTG ACT GGA CGG GGG
GTA AT-39 and 59-CAA AAC ACT CCC TTA CGC-39/SetB:
59-GTC TGT TTC GTA CCC GCC G-39 and 59-AAG CTC
AGG ATG TGC ATG TTC CA-39/kmp11 specific primers: 59-
GCC TGG ATG AGG AGT TCA ACA-39 and 59-GTG CTC
CTT CAT CTC GGG-39. SetA and SetB were based on LRV1-4
genome sequence (GenBank accession number: NC003601) and L.
major kmp11 gene as described previously [14]. LRV transcript
levels were quantified in triplicate relative to the Leishmania kmp11
housekeeping gene. Analysis and acquisition of data were
performed with the LightCycler software 1.5 (Roche) using the
22DDCT method.
Anti-capsid antibody production and immunoblotting
The LRV capsid open reading frame was amplified from a
cDNA preparation of Lg M5313 and cloned in a pET-28a E. coli
expression vector (Merck). Its sequence was found to be highly
similar to the capsid sequence of Lg M4147 LRV1-4 (more than
98% identical residues, Genbank accession number: JX313126).
Recombinant capsid was purified, using a HIS-tag, then used for
rabbit immunization (Covalab, polyclonal antibody identification
code: g018d53). Proteins from total parasite extracts were
quantified by BCA, 40 mg was loaded and separated on a 10%
polyacrylamide denaturing gel, transferred to a nitrocellulose
membrane and vizualised by Ponceau Red staining. After a 1 h
blocking step in 5% powdered milk diluted in TBS+0.05%
Tween20, the membrane was incubated overnight at 4uC with the
g018d53 anti-capsid polyclonal antibody (1:5000 in 1% milk TBS-
Tween20). Following 4 washes of 15 min at RT, the membrane
was incubated for 1 h with an anti-rabbit IgG antibody coupled to
peroxidase (Promega) (1:2500 in 1% milk TBS-Tween20), washed
again 46 and finally revealed by ECL chemiluminescence
(Amersham).
Peptide arrays on cellulose membranes and epitope
mapping
For antibody epitope screening, seventy-four 20-mer over-
lapping peptides (with an overlap of 10 residues) that cover the
whole sequence of Lg M4147 LRV1-4 capsid (Genbank accession
number: NC003601) were synthesized and attached to cellulose
membranes by the Protein and Peptide Chemistry Facility
(University of Lausanne).
The peptides were synthesized by using Intavis MultiPep
synthesizer (Intavis Bioanalytical Instruments AG, Cologne,
Germany). The cellulose membrane used was an Amino-
PEG500-UC540 sheet (acid-hardened with improved stability).
The membrane peptide linker was stable in wide range of aqueous
pH (pH 0–pH 14) at ambient temperature for 12 hours. The PEG
spacer consisted of 8–10 ethylene glycol units and had free
terminal amino groups to start the peptide synthesis. The Amino-
PEG500 spacer was loaded at 400 nmol/cm2 with a typical spot
diameter of 4 mm and therefore an average of 50 nmol peptide/
spot. The peptides were synthesized by stepwise solid phase
synthesis. Amino acids that had N-terminal/side-chain protecting
groups were spotted (if required) by robot. The amino acid
solutions were activated using diisopropylcarbodiimide/hydroxy-
benzatriazole chemistry. For each cycle, solutions of the 20
common amino acids were dispensed along with solutions of
modified amino acids as required (e.g. phosphorylated amino
acids, acetylated amino acids, methylated amino acids). Following
addition of the first amino acids, the membranes were treated to
prepare the spots for the next in sequence. This was done by
removing the N-terminal protective group (Fmoc) by piperidine.
This cycle was repeated until the peptides reached the required
length. Arrays were then treated with trifluoroacetic acid to reveal
the native side chains. Arrays were stored at 220uC prior to use.
Similarly to the classic nitrocellulose membranes as described
above, these peptide-spotted membranes were incubated with the
g018d53 anti-capsid polyclonal antibody (1:5000) to allow the
determination of the epitopes for which it was specific.
LRV sequencing
Lg 1398 LRV genome was partially sequenced as follows: first,
viral dsRNA was obtained from approximately 109 stationary
phase promastigotes after total nucleic acids extraction and RQ-
DNase digestion of genomic DNA (see ‘‘Viral dsRNA extraction
from total nucleic acids’’ section) and purification of the 5.3 kb
band after 0.8% agarose gel electrophoresis using Wizard SV gel
and PCR clean-up system (Promega). Viral cDNA was then
synthesized as described above (‘‘Quantitative real-time PCR’’
section) and 10–50 ng was used for PCR amplification with 0.4 ml
Leishmania RNA Virus Detection
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of GoTaq DNA polymerase (Promega) in its buffer supplemented
with Q solution (Qiagen), 0.4 mM dNTPs (Promega) and 0.3 mM
of each oligonucleotides (Microsynth, Switzerland). The PCR
reactions consisted of 35 cycles: 1 min at 94uC, 1 min at 55uC and
2 min at 72uC. Two PCR fragments were generated and
sequenced (by Fasteris, Switzerland) with the following oligonu-
cleotides: i) 59-GGA TCC GAA ACG TAA GCA AGT TTC
TTG-39 and 59-CCA ATA CCA TGG CGC CAT CAC ATT
CAT-39 (based on LRV1-1 and 1-4 sequences) and ii) 59-GAG
AAA TAG CGA TAT CGC AGC CCA A-39 (based on Lg 1398
LRV sequence obtained from previous reaction) and 59-CAC
AGC CAA CGT GAC GAC CAG AAA TCA C-39 (LRV1-4).
These two products allowed us to obtain 3.3 kb of Lg 1398 LRV
genome sequence including the complete open reading frame of
the viral capsid.
Immunofluorescence microscopy (IFM)
Two different protocols were used. In protocol A, stationary
phase promastigotes were fixed with 4% formaldehyde in PBS for
20–30 min (or overnight in 1% at 4uC), washed and resuspended
at 26107 parasites/ml then attached to poly-lysine (Sigma) coated
slides (Thermo Scientific) for 30 min at RT. After a 10 min
permeabilization step in PBS+0.1% TritonX-100 (PBS-TX), cells
were blocked for 45–60 min in 2% bovine serum albumin (BSA,
Acros Organics) in PBS-TX, and incubated overnight at 4uC with
the rabbit g018d53 anti-capsid polyclonal antibody (1:5000) or the
mouse anti-dsRNA J2 antibody (1:800, English & Scientific
Consulting) in 1% BSA in PBS-TX. Cells were then washed 46
in PBS, incubated for 1 h with a goat anti-rabbit IgG coupled to
Alexa Fluor 594 (1:2000, Invitrogen) or a goat anti-mouse
antibody coupled to Alexa Fluor 488 (1:600, Invitrogen) in 1%
BSA in PBS-TX. These were washed twice, incubated 10–30 min
with 0.5 mg/ml 49,6-Diamidino-2-phenylindole (DAPI, Invitro-
gen), washed again and finally mounted with Vectashield diluted
1006 in DABCO mounting solution (90% glycerol, 10% PBS and
2.5% DABCO from Sigma) or using Permafluor (ThermoScien-
tific). Fluorescence visualization was performed with an Upright
Axio Microscope at the Cellular Imaging Facility (CIF Epalinges,
University of Lausanne).
In protocol B, 106 parasites were fixed with 2% paraformalde-
hyde in PBS for 2 min. Cells were washed once in PBS and
adhered to glass coverslips (Fisherbrand) by centrifugation (500 g
for 2 min). Cells were permeabilized in blocking buffer (5%
normal goat sera, 0.1% Triton-X100, 16PBS) for 30 min at room
temperature then incubated with mouse anti-dsRNA J2 antibody
(1:1000) for one hour. Cells were then washed 36 in PBS and
incubated with goat anti-mouse IgG AlexaFluor 488 (1:1000,
Invitrogen) for one hour. After washing again in PBS (36),
coverslips were rinsed briefly in water and mounted using Prolong
Gold (Invitrogen). Microsocopy was performed using Olympus
AX70 microscope and images were obtained using QCapturePro
software (Version 5.1.1.14). Image analysis was performed using
Image J (1.45).
Slot blot
56106 parasites were resuspended at a final concentration of
56105 cells/ml in PBS. 100 ml were adhered to nitrocellulose
membranes using Mini-fold II Slot-Blot System (Schleicher &
Schuell, Keane, NH). The membrane was incubated in 2%
powdered non-fat milk for 1 h, then with mouse anti-dsRNA J2
antibody (1:2000) and polyclonal rabbit anti-histone H2A (1:2000;
Wong and Beverley, in preparation) in 2% milk plus 0.2% Tween
20 for 1 h. The membrane was washed in 16PBS plus 0.1%
Tween 20 (PBS-T) 36 and incubated in goat anti-mouse IRDye
800 and goat anti-rabbit IRDye 680 (1:10000 each, Licor
Biosciences, Lincoln, NE) for 1 h. The membrane was washed
36 in PBS-T and once in 16PBS. Analysis was performed using
the Odyssey Infrared Imaging System and Application Software
Version 3.0.16 (LiCor Biosciences). The cut-off point was
calculated as 3 standard deviations (S.D.) above the mean
absorbance of the LRV negative control.
ELISA
Stationary phase promastigotes (108 parasites/ml) were lysed in
PBS+0.5% Nonidet P40 (NP40). 20 mg of total proteins, equating
to approx. 56106 parasites (as quantified with BCA assay) were
adhered to a 96 well plate (Thermo Scientific), which had been
pre-coated with poly-lysine (Sigma), overnight at 4uC. After 4
washes in PBS 0.05% Tween20 (PBS-Tw20), lysates were blocked
in assay diluent solution (eBioscience) for 2 h at RT, washed again
in PBS-Tw20, and incubated for 1 h at 37uC with the primary
mouse monoclonal anti-dsRNA J2 antibody (1:2000, English &
Scientific Consulting). After 4 more washing steps, a secondary
anti-mouse IgG HRP conjugated antibody (1:2500, Promega) was
added for 1 h at 37uC. Wells were then washed and dsRNA could
be colorimetrically quantified by the addition of o-Phenylenedia-
mine dihydrochloride (OPD) in a phosphate citrate buffer (Sigma).
The reaction was stopped by acidification with 0.5 M H2SO4 and
measured at 490 nm with a Biotek Synergy HT spectrophot-
ometer. The cut-off point was calculated as 3 standard deviations
(S.D.) above the mean absorbance of the LRV negative control.
Dot blot
Stationary phase promastigote pellets were resuspended in
16PBS, and a small amount was lysed for BCA quantification in
0.5% NP40. Parasite samples in PBS were then adjusted to
0.1 mg/ml of total protein and spotted onto a nitrocellulose
membrane using a range of 0.5 to 4 mg of protein per spot
(corresponding to approx. 105 to 106 parasites). To test the
sensitivity of the method, live parasites were counted, serially
diluted between a range of 10 to 1000 parasites and directly
spotted on the nitrocellulose membrane. The membranes were
then dried before revelation by immunodetection as described
above (see ‘‘Anti-capsid antibody production and immunoblot-
ting’’ section), using an anti-dsRNA J2 primary antibody (1:1000,
English & Scientific Consulting) and an anti-mouse IgG HRP
conjugated secondary antibody (1:2500, Promega).
Mouse infection and RNA extraction from leishmaniasis
lesions
One million stationary phase Lg M4147 LRVhigh or Lg M4147
LRVneg promastigotes were injected subcutaneously into the base
of the hind footpad of C57BL/6 mice. Lesions were isolated at the
peak of infection (approx. 4 weeks post-infection) and homo-
genized with a mortar and a pestle in PBS. After an initial
centrifugation step to remove large debris (50 g for 2 min), cell
supernatant was centrifuged again (600 g for 8 min) and the pellet
was directly resuspended in Trizol for total RNA extraction (as
described in ‘‘qRT-PCR’’ section). Approximately 50 mg of RNA
was obtained from each lesion (40–50 mg) and diluted in water for
dot blot analysis with the J2 antibody (see ‘‘Dot blot’’ section).
Results
In order to characterize the presence and burden of LRV in L.
(Viannia) parasite strains via different methods, we first tested four
parasite isolates of varying LRV content [14]. Two clones derived
from the L. guyanensis M4147 strain were used: Lg M4147 LRVhigh,
Leishmania RNA Virus Detection
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known to have a high burden of LRV and Lg M4147 LRVneg in
which LRV is undetectable by RT-PCR tests [25]. In addition, we
also tested two human isolates of L. guyanensis: Lg 1398, derived
from a metastatic lesion and known to bear high levels of LRV and
Lg 1881, from a CL patient and in which LRV is present at a very
low level (at least 10’000 fold less [14]). To best compare the
various LRV detection techniques, each was performed on
material from a single sample preparation (except for the slot
blot). The data shown are representative of the trend gleaned from
several independent experiments.
LRV detection by gel electrophoresis and quantitative
real-time PCR
As a starting point, LRV content was estimated using two
previously used methods [14]. Firstly, total nucleic acids were
extracted from promastigote cultures and analyzed by agarose gel
electrophoresis. Here, a 5.3 kb band corresponding to the size of
the viral dsRNA genome was detectable in Lg M4147 LRVhigh and
Lg 1398 extracts, which was weaker in the latter (Figure 1A, upper
panel). This band could be seen more clearly when parasite
genomic DNA was eliminated by DNase treatment (Figure 1A,
lower panel). As expected, LRV dsRNA was not detectable in Lg
M4147 LRVneg or in the LRVlow strain Lg 1881. Using a serial
dilution of nucleic acids from LRV-infected parasites, we
estimated that the amount of LRV dsRNA was approximately
three to four times higher in Lg M4147 LRVhigh than in Lg 1398
(Figure 1B).
We then quantified LRV transcript levels, after RNA extraction
followed by cDNA synthesis, using two different primer sets that
we have already successfully used for LRV detection in Lg M4147
and Lg M5313 strains and their clonal derivatives: SetA, which
amplified a 124 nucleotide fragment on the 59-end of the viral
RNA (nucleotide 153 to 277 of the LRV1-4 sequence) [14], and
SetB, which amplified a 103-nucleotide fragment in the RdRp open
reading frame (nucleotide 3591 to 3694 of LRV1-4). Quantitative
RT-PCR was performed and normalized to both the amplification
obtained from the conserved kmp11 housekeeping gene and the
signal obtained from Lg M4147 LRVhigh. With the SetA primers,
Lg 1398 showed nearly half the LRV transcripts than Lg M4147
LRVhigh, while the Lg M4147 LRVneg line and Lg 1881 showed no
detectable LRV product. Notable is that no product was obtained
with the SetB primers from Lg 1398 despite having high levels of
LRV (Figure 1B vs Figure 1C). Preliminary sequencing data of the
Lg 1398 LRV RdRp open reading frame explained this negative
result (H. Zangger, unpublished data), and illustrated a potential
problem of a PCR-based approach for LRV screening in
uncharacterized parasites.
LRV detection by a capsid-specific antibody
Detection of LRV can also be performed via the recognition of
viral proteins [27]. A high-affinity rabbit polyclonal antibody
(g018D53) was raised against the capsid polypeptide of Lg M5313
LRV (.98% identical to Lg M4147 LRV1-4, Genbank accession
number: JX313126) and then tested on control strains by
immunoblotting and fluorescence microscopy. With both techni-
ques, LRV detection was achieved in Lg M5313 (and its derivative
LRVhigh clones, Lg 13 and Lg 21; data not shown) as well as in Lg
M4147 LRVhigh, showing a strong staining throughout most of the
cytosol of promastigotes (Figures 2A and 2B). As expected, no
staining was visible in Lg 17 (LRVlow derivative clone of Lg
M5313), Lg M4147 LRVneg and Lg 1881, but neither in the LRV-
infected human isolate Lg 1398 which is probably due to LRV
sequence diversity. Partial Lg 1398 LRV sequencing was
performed and surprisingly revealed a high identity of its capsid
Figure 1. Detection of LRV in nucleic acid extracts. A and B. Visualization of viral genomic dsRNA by gel electrophoresis. A. Total
nucleic acid from stationary phase promastigotes was treated with ssRNase then migrated in a 1% agarose gel. The sample was either kept intact
(1 mg, upper panel) or digested with RQ-DNase (5 mg, lower panel). B. To quantify viral dsRNA in Lg 1398 relative to Lg M4147 LRVhigh, various
concentrations of nucleic acid (2, 1 and 0.5 mg) were digested with RQ-DNase and migrated as above. C. Quantification of LRV transcript by
qRT-PCR. Total parasitic and viral cDNA was prepared for qRT-PCR and amplified using primers specific for LRV (SetA and SetB, see material and
methods for sequences). Viral transcript was quantified as normalized to the parasitic housekeeping gene kmp11 then adjusted relative to Lg M4147
LRVhigh.
doi:10.1371/journal.pntd.0002006.g001
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as compared to Lg M4147 throughout the entire open reading
frame (91% identical residues, Genbank accession number:
JX313127). Epitopes mapping using a 20-mer peptide arrays
representing the complete Lg M4147 LRV capsid sequence
showed that g018D53 recognized uniquely Lg M5313 LRV C-
terminal capsid sequence, which is poorly conserved in Lg 1398,
thus explaining why it is not recognized by g018D53 in this strain
(Figure 2C and 2D).
Immunodetection of LRV by a dsRNA-specific antibody
The J2 monoclonal mouse antibody directed against dsRNA
allows the detection of various dsRNA viruses independently of
their sequences [28,29]. To gauge its utility for LRV detection, it
was first tested on control parasites by fluorescent microscopy
using two different fixation protocols (Figures 3A and 3B). For
both protocols the staining pattern with the J2 antibody was
similar to that seen with the anti-capsid antibody (Figure 2B).
Interestingly, a signal was obtained with the strain Lg 1398,
suggesting that the anti-dsRNA antibody was not limited by
differences in sequence amongst LRVs as noted earlier in the
qRT-PCR and anti-capsid studies.
From the images acquired via the second protocol (Figure 3B),
histograms were constructed to show the distribution of signal
intensity between individual cells (Figure 3C). A distinct peak was
seen in the Lg M4147 LRVhigh line that was quite separated from
that obtained with the LRVneg line or controls (Figure 3C). The
spread of the Lg M4147 LRVhigh peak was somewhat broader than
might have been anticipated for a homogeneous population,
Figure 2. Detection of LRV with a polyclonal anti-capsid antibody (g018d53) and epitope mapping. A. Western blot. Total parasitic
protein extract (40 mg) was separated on a 10% acrylamide denaturing gel then transferred onto a nitrocellulose membrane where the LRV capsid
could be detected using the rabbit polyclonal antibody g018d53 (upper panel). A Ponceau staining of the same membrane shows total parasitic
protein (lower panel). B. Immunofluorescence microscopy. Red: capsid (g018d53 Ab). Blue: DAPI integrated into kinetoplast and nuclear DNA.
Capsid immunofluorescence was visualized with a standardized exposure time in all images. C. 74 overlapping peptides (20-mer) covering the
complete sequence of Lg M4147 LRV1-4 capsid were spotted on a cellulose membrane (30 peptides per lane as indicated) and incubated with the
g018d53 antibody to identify the recognized epitopes. D. Sequence alignment of the LRV capsids from Lg M4147, Lg M5313 and Lg 1398 in the C-
terminal region covering the epitopes recognized by the g018d53 antibody (shown in C). The residues that are not identical to the Lg M5313 LRV
sequence are highlighted in a black box.
doi:10.1371/journal.pntd.0002006.g002
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suggesting some heterogeneity in LRV levels may exist. Similar
results have been obtained with anti-capsid antisera (FMK and
SMB, not shown).
We also tested the use of a slot-blot technique for estimating
LRV load. In this protocol, cells were ‘slotted’ onto nitrocellulose
membranes and reacted with J2 to detect dsRNA and anti-histone
H2A to control for parasite numbers. Clear differences in LRVhigh
and LRVneg parasites were again observed (Figures 4A and 4B).
Both logarithmic and stationary cells were tested showing that the
dsRNA signal intensity does not significantly change during
culture of the parasite.
The results obtained in IFM or ‘slot’ blotting prompted us to
explore more rapid and simple protocols for the use of the J2 anti-
dsRNA antibody that may be suitable for screening of field
isolates, where sequence divergence amongst LRVs is expected. It
was thus transferred to the other immunodetection techniques of
ELISA and dot blot. The J2 ELISA method used crude parasite
lysate (NP40); it allowed relative quantitation of LRV and
confirmation that it was approximately four times more abundant
in Lg M4147 LRVhigh than in Lg 1398 (Figure 5A). However a
clear limitation of this approach is the requirement for high LRV
load as illustrated here with a relatively low signal obtained with
the Lg 1398 strain in comparison to LRV-low/negative strains.
Dot blot tests were performed with whole live parasites spotted
directly on nitrocellulose membranes. Distinction between infected
or non-infected promastigotes was remarkably reliable (Figure 5B),
permitting a relative quantification that reproduced the difference
in LRV load between Lg M4147 LRVhigh and Lg 1398 (Figures 1B
and 5A). In addition to being a simple technique that is
independent of LRV sequence, the dot blot had the advantage
of only requiring a very low number of parasites as shown in
Figure 5C. Here, LRV could be detected in less than a hundred
parasites from the Lg M4147 LRVhigh line.
Screening for LRV infection in human isolates
To assess the applicability of our anti-dsRNA dot blot on field
isolates, we used it for LRV screening in human isolates from
another Leishmania species that had been previously typed and
catalogued as LRV positive [24]. Five strains were screened,
corresponding to L. braziliensis isolated from human lesions
(Figure 6). As expected, we were able to confirm LRV presence
in these isolates. This study suggested that the dot blot method
Figure 3. Detection of LRV with a monocolonal anti-dsRNA (J2) antibody by immunofluorescence microscopy. A. Reference strain
analysis (protocol A, see ‘‘Material and methods’’). Green: dsRNA (J2 Ab). Blue: DAPI (standardized exposure time in all images). B. Phase and
immunofluorescent images of Lg M4147 LRVhigh or LRVneg cells were obtained in the presence or absence of J2 antibody (protocol B). C. Quantitative
immunofluorescence (protocol B). The fluorescent intensity per cell was assessed using Image J software on Lg M4147 LRVhigh or LRVneg cells
following IFM with the J2 antibody. Cells from phase images were identified and the fluorescent intensity average over the area of the cell was
recorded. 108–160 cells from 2 distinct fields were measured, and histogram plots were made using Excel software. LRVhigh, no primary antibody
(&, dashed line); LRVhigh with J2 (&, solid line); LRVneg, no primary antibody (N, dashed line); LRVneg with J2 (N, solid line).
doi:10.1371/journal.pntd.0002006.g003
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using J2 was a valid approach that can be extended to clinical
Leishmania isolates from human biopsy.
Screening for LRV presence in L. braziliensis isolated from
an infected patient
To demonstrate that our anti-dsRNA immunodetection ap-
proach may be a relevant diagnostic tool in a clinical setting, it was
tested on freshly isolated Leishmania parasites obtained from an L.
braziliensis infected patient. The subject contracted leishmaniasis in
Bolivia, which was later typed by PCR as being L. braziliensis (data
not shown). Two parasite samples were taken: Lb 2169 and Lb
2192, derived respectively from a primary cutaneous lesion before
treatment, and a secondary/metastatic lesion appearing some time
after treatment had started. Parasites from these biopsies were
cultivated and directly tested for LRV presence by dot blot using
the anti-dsRNA antibody as described above. Lg M4147 LRVhigh
and Lg M4147 LRVneg parasites were used as positive and
negative controls respectively. As shown in Figure 7A, a clear
signal, although weaker than for Lg M4147 LRVhigh, was detected
in both parasite isolates from this infected patient. To ascertain
Figure 4. Detection of LRV using slot blots and J2 antibody. A. 56104 parasites were blotted onto nitrocellulose membranes and incubated
with J2 or anti-histone H2A antibodies. B. Quantification of the signal intensity for cells in logarithmic or stationary growth phase: dsRNA signal was
quantified relative to the histone H2A signal. The cut-off line was calculated as 3 standard deviations (SD) above the mean absorbance of the LRV-
negative that showed the highest value (log phase).
doi:10.1371/journal.pntd.0002006.g004
Figure 5. Detection of LRV in total parasite lysate using J2 antibody. A. ELISA. Total lysates from 56106 promastigotes were coated on 96
wells plates and dsRNA was quantified colorimetrically at 490 nm relative to Lg M4147 LRVhigh after background subtraction (uncoated control wells).
The cut-off line was calculated as 3 standard deviations (SD) above the mean absorbance of the LRV-negative that showed the highest value (Lg
1881). B. Dot blot. 105 to 56105 promastigotes were spread directly onto a nitrocellulose membrane and dsRNA was detected using the J2 antibody
(upper panel). A Ponceau stain of the membrane shows total protein concentration was similar across samples (lower panel). C. Dot blot sensitivity
screening. A dot blot was performed in a serial dilution of 1000 to 10 parasites from LRV-positive and negative control strains (Lg M4147 LRVhigh and
Lg M4147 LRVneg).
doi:10.1371/journal.pntd.0002006.g005
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that this positive signal was genuinely due to the presence of LRV,
the samples were retested using some of the other LRV detection
techniques, i.e. immunofluorescence microscopy (Figure 7B) and
isolation of viral dsRNA, with clear detection of a ssRNase- and
DNase-resistant 5.3 kb band (Figure 7C). Sequencing of this newly
identified LRV is currently in progress. Because the presence of
LRV may be an aggravating factor in the development of
refractory metastatic disease, early diagnosis of LRV content may
aid diagnosis and be used to guide treatment strategies. This
experiment demonstrated the ease and accuracy of dsRNA
detection and reinforced the broad applicability of the anti-
dsRNA antibody in the detection of LRV across Leishmania species.
Screening of LRV in footpad lesions
Although these results suggest that our J2 antibody might have
the potential to detect LRV for clinical application, a major
limitation could be the need for parasite isolation from biopsy
lesions, which is not always easy to achieve in the field. It was
therefore important to test its direct applicability from lesions, thus
avoiding parasite cultivation. A proof-of-concept study was
performed on murine leishmanial lesions. After a simple RNA
extraction with Trizol from leishmanial lesions of mice infected
with Lg M4147 LRVhigh or Lg M4147 LRVneg, we tested for the
presence of LRV. As shown in Figure 8, LRV was only detected in
lesion extracts from Lg M4147 LRVhigh but not in Lg M4147
LRVneg. Importantly, it was visible in as little as 25–50 ng of total
RNA extract, which corresponds to a clinically minute biopsy size
(approximately 20–50 mg of lesion). This result showed that, not
only we can detect LRV in promastigotes but also in amastigotes
Figure 6. Screening for LRV in human isolates of Leishmania.
Parasites of 5 different L. braziliensis strains previously shown to harbor
LRV [24] were analyzed by dot blot (1 to 4 mg total protein/spot).
doi:10.1371/journal.pntd.0002006.g006
Figure 7. Screening for LRV in freshly-isolated human L. braziliensis. A. Dot blot analysis of two parasite samples obtained from separate
lesion biopsies in an infected patient: Lb 2169 and Lb 2192. Live parasites (1 to 4 mg total proteins) were spotted on a nitrocellulose membrane for
LRV dsRNA detection by dot blot (J2 antibody). Lg M4147 LRVhigh and LRVneg were used as positive and negative controls. Upper panel: dsRNA
detection by dot blot (J2). Lower panel: verification of protein quantity by Ponceau staining. B. J2 anti-dsRNA analysis of Lb 2169 by fluorescence
microscopy. Green: dsRNA (J2 Ab). Blue: DAPI. C. Isolation of viral genomic dsRNA from the Lb 2169 strain. Intact and DNase-digested total nucleic
acids from Lb 2169 parasites and Lg M4147 LRVhigh as a control, were analyzed by gel electrophoresis (similarly to Figure 1A). Note: with high
resolution gels such as presented here (in contrast to Figure 1), the viral genome often appears as a doublet.
doi:10.1371/journal.pntd.0002006.g007
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in lesion lysates, suggesting that this detection method has great
potential for use in the field.
Discussion
The presence of LRV in Leishmania (Viannia) species is suspected
to be a major aggravating factor in the dissemination and
persistence of leishmaniasis. Therefore, the detection of LRV
might prove clinically beneficial, guiding treatment or providing
prognostic information. In this study, we evaluated several
approaches of LRV detection, starting with the identification of
a 5.3 kb viral dsRNA band in total parasitic nucleic acid
(Figure 1A) [14]. This method, however, had the marked
disadvantage of requiring at least 108 parasites and a high LRV
load. On the contrary, the qRT-PCR approach is both highly
sensitive as well as quantitative but its use as a first line diagnostic
could be limited in the field in case of LRV genetic polymorphism
(as illustrated with the SetB primers in Figure 1C). Further work
would be required to identify the highly conserved regions
amongst all LRV genomes in divergent parasite strains in order
to avoid such a problem. Immunodetection by anti-LRV
antibodies also proved to be clinically applicable with the
advantage of qualitative analysis by fluorescence microscopy,
revealing an interesting cytosolic clustering of viral particles
(Figure 2B). Anti-capsid antibodies, however, have the same
potential limitation as qRT-PCR due to their dependence on the
underlying capsid sequence.
In this report, we describe new sequence-independent LRV
detection techniques, using the anti-dsRNA J2 antibody, which
could then be used in the field against any LRV strain
circumventing the problem of sequence specificity that could
occur. It was found to be effective and quantitative in microscopy,
slot blot, ELISA and dot blot assays using parasites or lesions
Figure 8. Detection of LRV in mice footpad lesions. Dot blot
analysis on total RNA extracted from mice lesions infected with Lg
M4147 LRVhigh and Lg M4147 LRVneg. Whole parasite (‘total’) and RNA
extracts from Lg M4147 promastigotes were also loaded as a control.
The amount of protein and RNA loaded is indicated on the left and right
side of the figure respectively.
doi:10.1371/journal.pntd.0002006.g008
Table 1. LRV status of the analyzed strains according to detection method.
dsRNA WB + IFM IFM SB ELISA DB
LRV load Strain extraction qRT-PCR (capsid Ab) (J2) (J2) (J2) (J2)
High Lg M4147 LRVhigh +a +a + + + + +
Lg 1398 +a +1 a 2 + + +
Lg M5313 +* a,b +* a + +* +* +*
Lg 13 +* a +* a +* +* +*
Lg 21 +* a +* a +* +* +*
Lb 1064 +* b +
Lb 1174 +* b +
Lb 1403 +* b +
Lb 1407 +* b + +
Lb 2169 + +* +
Lb 2192 +
Low Lg 1881 2a 2a 2 2 2 2
Lg 03 2* a 2* a 2* 2* 2*
Lg 17 2* a 2* a 2 2* 2* 2*
Negative Lg M4147 LRVneg 2a 2a 2 2 2 2 2
aAs shown in Ives et al., 2011; by qRT-PCR analysis, Lg 1881, Lg 03 and Lg 17 were classified as LRVlow harboring at least 10,000 fold less viral transcripts than the highly
infected strains.
bAs shown in Salinas et al., 1996.
*Performed in this study but not shown in the figures.
1Only with specific primers.
Abbreviations: WB=western blotting/IFM= immunofluorescence microscopy/SB = slot blot/DB = dot blot.
doi:10.1371/journal.pntd.0002006.t001
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extracts, where it detected LRV in all LRV-positive control
strains. All the strains analyzed in this study and the results
obtained from each method are summarized in Table 1. The anti-
dsRNA-based dot blot technique stood out as the candidate
method for use in the field, having sufficient sensitivity and ease of
use to allow rapid LRV detection at a relatively low cost that could
be performed at a large scale in a clinical setting (Table 1).
In our previous analysis [14], we showed that the metastatic
parasites in the Golden hamster model as well as a human ML
isolate were positive for LRV, while non-metastatic and a human
CL-derived strain were negative or very poorly infected. From the
analysis reported here, we could detect the presence of LRV in
other Leishmania isolates, including again L. guyanensis, but in
addition in freshly isolated L. braziliensis parasites from human
lesions. Finally, we showed that LRV could also be detected
directly from minute lesion biopsies in mice thus avoiding parasite
isolation and promastigote cultivation, which is a clear advantage
when adapting of the technique such a diagnostic technique for
field applicability. We propose that this approach could now be
finalized for use on a mass-scale to determine the prevalence of
LRV in L. (Viannia). This would greatly aid in confirming the
correlation between LRV presence and clinical phenotype. If a
significant trend is established, LRV detection could be used as a
prognostic tool, perhaps guiding treatment strategies to prevent
the metastatic complications often observed in some Leishmania
(Viannia) infected patients.
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